Welcome to our dedicated page for ABERCROMBIE & FITCH CO /DE/ SEC filings (Ticker: ANF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ABERCROMBIE & FITCH CO /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ABERCROMBIE & FITCH CO /DE/'s regulatory disclosures and financial reporting.
Abercrombie & Fitch Co. executive Scott D. Lipesky, EVP and COO, reported selling 10,000 shares of Class A Common Stock on July 16, 2026 at $100.00 per share. After this sale, he directly owns 182,534 shares. The transaction occurred automatically under a Rule 10b5-1 trading plan adopted on March 6, 2026.
A holder of ANF Class A shares plans a potential sale of up to 10,000 shares through Fidelity Brokerage Services LLC on the NYSE. The shares have an indicated aggregate value of $1,000,000.00, with a proposed sale date of July 16, 2026.
The shares were acquired from the issuer as compensation through restricted stock vesting, including grants on March 1, March 23, and April 1, 2024.
Abercrombie & Fitch director Nigel Travis reported multiple equity compensation moves involving Class A common stock and restricted stock units. He exercised restricted stock units to acquire 3,355 Class A shares at a price of $0.00 per share, bringing his direct holdings to 24,455 shares of common stock. On the same date, he also exercised 1,266 and 2,089 restricted stock units, each convertible into one common share, fully settling those awards. In addition, he received new grants of 1,309 and 2,160 restricted stock units as compensation, each representing a contingent right to one share of common stock. The footnotes state that these restricted stock units generally vest on the earlier of the first anniversary of grant or the next regularly scheduled annual meeting of stockholders, with one award tied to his service as Board Chairperson.
Abercrombie & Fitch director Kenneth B. Robinson reported routine equity compensation activity involving company stock. He exercised 2,089 Restricted Stock Units into 2,089 shares of Class A Common Stock, leaving him with 7,969 common shares held directly after the transaction.
On the same date, he also received a grant of 2,160 new Restricted Stock Units, increasing his RSU balance to 4,249 units. Each RSU represents a contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders.
Abercrombie & Fitch Co. director Arturo Nunez increased his equity stake through stock-based compensation. On June 3, 2026, he exercised restricted stock units that delivered 2,089 shares of Class A Common Stock, bringing his direct common stock holdings to 2,869 shares.
On the same date, he received a new grant of 2,160 restricted stock units, raising his direct RSU holdings to 4,249 units. Each restricted stock unit represents a contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders.
Abercrombie & Fitch director Helen McCluskey increased her equity stake through compensation-related stock activity. She exercised 2,089 restricted stock units into Class A Common Stock at a stated price of $0.00 per share, bringing her direct holdings to 36,839 shares. She also received a new grant of 2,160 restricted stock units, bringing her total restricted stock units to 4,249. Each restricted stock unit represents a contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders. The filing shows no open‑market purchases or sales.
Abercrombie & Fitch Co. Chief Executive Officer Fran Horowitz reported a bona fide gift of 25,000 shares of Class A Common Stock. The transfer carried a stated price of $0.00 per share, reflecting that it was a non-cash charitable or personal gift rather than a market sale.
Following this gift, Horowitz directly holds 492,793 shares of Class A Common Stock. The filing does not show any option exercises or open-market buying or selling, so this update mainly reflects a change in how her existing ownership stake is allocated.
Abercrombie & Fitch Co. director Helen Vaid exercised restricted stock units into common shares. On June 3, 2026, she converted 2,089 Restricted Stock Units into 2,089 shares of Class A Common Stock, a compensation-related equity transfer rather than an open-market trade.
After this exercise, she directly holds 7,161 shares of Class A Common Stock. Each restricted stock unit represented a contingent right to receive one share, with vesting tied to the earlier of the first anniversary of the grant date or the next annual meeting of stockholders.
Abercrombie & Fitch director James A. Goldman reported equity compensation-related transactions. On June 3, 2026, he exercised restricted stock units to acquire 2,089 shares of Class A common stock at a stated price of $0.00 per share, increasing his direct holdings to 9,654 shares.
On the same date, he also reported derivative entries in restricted stock units. One entry reflects the exercise of 2,089 restricted stock units into Class A shares, and another reflects a new grant of 2,160 restricted stock units, bringing his restricted stock unit balance to 4,249 units. Each restricted stock unit represents a contingent right to receive one Class A share and vests on the earlier of the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders.
Abercrombie & Fitch Co. director Suzanne M. Coulter reported routine equity compensation and related conversions. She exercised derivative securities covering 2,089 restricted stock units and 2,089 phantom stock units into rights tied to Class A common stock at a stated price of $0.00 per unit. She also received a new grant of 2,160 restricted stock units, bringing her direct restricted stock unit holdings to 4,249 units after these transactions.
Each restricted stock unit and each share of phantom stock represents a contingent right to receive one share of Abercrombie & Fitch common stock. The new restricted stock units vest on the earlier of the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders. The phantom stock units become payable in common stock when Coulter’s service as a director ends, and following the conversion she holds 27,821.253 phantom stock units.